Guilin Sanjin Pharmaceutical Co., Ltd. at its 2nd Extraordinary General Meeting of 2023 on 14 November 2023 approved 2023 third quarter profit distribution plan. Cash dividend/10 shares (tax included): CNY 3.00000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.98 CNY | +1.08% | +4.76% | +3.38% |
04-26 | Guilin Sanjin Pharmaceutical Co., Ltd. Proposes Final Dividend for 2023 | CI |
04-25 | Guilin Sanjin Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.38% | 1.2B | |
+43.25% | 6.3B | |
-15.08% | 4.44B | |
-6.70% | 3.27B | |
+5.47% | 3.16B | |
+0.76% | 2.58B | |
+47.75% | 1.96B | |
-5.08% | 1.73B | |
+2.05% | 1.68B | |
-7.08% | 1.63B |
- Stock Market
- Equities
- 002275 Stock
- News Guilin Sanjin Pharmaceutical Co., Ltd.
- Guilin Sanjin Pharmaceutical Co., Ltd. Approves 2023 Third Quarter Profit Distribution Plan